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Background: Offset analgesia (OA) is an increasingly described phenomenon to measure 
endogenous pain inhibition, in which a greater decrease in pain intensity is experienced than would 
be predicted by the decrease in painful stimulation. The temporal filtering in this OA phenomenon 
differs from the spatial filtering in the commonly described conditioned pain modulation (CPM). 
Yet, the knowledge on the efficacy of OA in chronic pain patients is scarce, compared to CPM 
efficacy. 
Objective: This systematic review has been conducted to provide an overview of the current 
knowledge regarding OA, and to compare it to CPM.
Study Design: A systematic review of research studies that investigated the application or 
mechanisms of OA.
Setting: The present study took place at Ghent University and the University of Antwerp.
Methods: This systematic review follows the PRISMA guidelines. The electronic databases Pubmed 
and Web of Science were searched in January 2015. Full text clinical reports addressing OA were 
included. The checklists for randomized controlled trials, case-control studies, and cohort-studies 
provided by the Dutch Institute for Healthcare Improvement and the Dutch Cochrane Centre were 
used to assess methodological quality. The articles received a level of evidence A1, A2, B, C, or 
D, based on study design and risk of bias. These levels were used to determine the strength of 
conclusion (level 1 to 4).
Results: Seventeen articles met the inclusion criteria. Sixteen studies used quantitative sensory 
testing to provoke OA; however, differences in protocols are present.  OA can function as a non-
opioid mediated assessment tool for endogenous pain inhibition, and activates brain regions such 
as periaqueductal gray (PAG), dorsolateral prefontral cortex, insula, medulla, pons and cerebellum, 
indicating strong brain derived pain modulation. The primary somatosensory cortex is, conversely, 
less activated during OA. OA is decreased in neuropathic patients. Nonetheless, evidence for the 
influence of individual factors on OA is limited. OA and CPM seem to rely on different mechanisms.
Limitations: Search strategy was taken wide, wherefore a large variety of research perspectives 
were included. 
Conclusions: This systematic review displays OA as a temporal filtering mechanisms that is 
more brain-derived compared to the spatial assessment method CPM. There is strong evidence 
for reduced OA in neuropathic patients, however, evidence regarding OA in (sub)acute and central 
sensitization patients, and the influence of personal factors on OA is currently scarce and needs 
further investigation. 
Key words: Endogenous pain inhibition, pain modulation, OA, temporal filtering, CPM, spatial 
filtering, pain pathways
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stimulation is set with the same device, at the same 
place of the body. Therefore, dissimilar from the spatial 
filtering in CPM, OA is probably operating as a temporal 
filtering mechanism (16). OA can be defined as a great-
er decrease in pain intensity when going from a nox-
ious painful stimulus (T2) to an unpleasant stimulus (T3) 
than can be expected from the increase of pain intensi-
ty when transitioning from an unpleasant stimulus (T1) 
to a noxious painful stimulus (T2) (definition of OA, first 
described by Grill and Coghill (17)). This OA paradigm 
is presented in Fig. 1a. The large change in pain inten-
sity during OA is different from the adaptation and/or 
habituation that could occur during prolonged and/or 
repeated noxious stimulation (18,19). Accordingly, OA 
magnitude is measured by the largest VAS score at T2 – 
the lowest VAS score at T3, compared to the decrease in 
VAS rate during the control trial, presented in Fig. 1b. 
Although this definition is rather delineated, the exact 
mechanisms in OA are still unknown. 
OA and CPM are 2 paradigms, activating endog-
enous pain inhibition, that are often used as assessment 
tools in pain research. Although they seem to rely on 
a different rationale, the exact relation or difference 
between CPM and OA remains unclear. Especially, since 
different OA protocols are used and the knowledge 
on the efficacy of OA in chronic pain patients is scarce, 
compared to CPM efficacy. This systematic review has 
been conducted to provide an overview of the current 
Chronic pain is a widely described phenomenon. Prevalence figures reveal that approximately 19% of the European adult population is a 
target of chronic pain (1). In various chronic pain states, 
central pain modulatory pathways are affected. More 
specifically, dysfunctions of descending modulatory 
pathways are likely to lie at the basis of many chronic 
pain syndromes. Syndromes with already proven 
dysfunctional acting descending modulatory pathways 
include fibromyalgia (2-4), chronic fatigue syndrome 
(5,6), irritable bowel syndrome (7), complex regional 
pain syndrome (8), temporomandibular disorder (7), 
and whiplash associated disorders (9). 
Conditioned pain modulation (CPM) is commonly 
used as an assessment tool for measuring endogenous 
pain inhibition in current pain research (5,10,11). Re-
duced CPM-effects in central sensitization patients are 
extensively reported in the literature (5,9,12). CPM is a 
type of spatial filtering, measuring in particular diffuse 
noxious inhibitory controls (DNIC). In this paradigm, a 
painful stimulus applied to a distant area of the body 
(= conditioning stimulus), inhibits the pain response of 
another noxious stimulus (= test stimulus) (13-15). 
Another increasingly described method for mea-
suring endogenous pain modulation is offset analgesia 
(OA). OA is the larger decrease in perceived pain in-
tensity than would be predicted by the small decrease 
in noxious stimulation. This small decrease in noxious 
Fig. 1. Time period: 
T0: baseline temperature; temperature starts at baseline and increases to test temperature 
T1: unpleasant test temperature 
T2: painful stimulation 
T3: unpleasant test temperature
VAS: Visual Analogue Scale
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knowledge regarding OA, and to compare it to CPM. 
Unravelling such paradigms may steer further insight 
into the exact mechanisms behind (the failing of) en-
dogenous pain inhibition. 
Methods
This systematic review is reported following the 
PRISMA (Preferred Reporting Items for Systematic re-
views and Meta-Analyses) guidelines (20). 
Research Question
In order to conduct this systematic review, the 
Patient-Intervention-Comparison-Outcome-approach 
(PICO) was used. The following PICO-questions were 
formulated: (1) Which methods (O), in healthy partici-
pants, patients, or animals (P), could be used to measure 
OA (I), as paradigm for the assessment of endogenous 
pain inhibition? (2) Which mechanisms (O) are triggered 
by OA (I) in healthy participants, patients, or animals 
(P)? (3) Are there personal factors (P) influencing the 
endogenous pain inhibition (O) measured by OA (I)? (4) 
Can OA (I) be used to measure inefficient endogenous 
pain inhibition (O) in patients (P)? (5) Is OA (I) related to 
the same mechanisms (O) as CPM (C) to establish endog-
enous pain inhibition in healthy participants, patients, 
or animals (P)?  
Search Strategy
The databases PubMed and Web of Science were 
searched in January 2015 using a combination of search 
terms. Key words and mesh terms were listed for each 
part of the PICO and are represented in Table 1. Search 
terms for I were placed between quotation marks, be-
sides, I without quotation marks was combined with the 
search terms formulated for C or O using the Boolean op-
erator ‘AND.’ Various synonyms of the search terms for 
C and O were entered using the Boolean operator ‘OR.’ 
Hand searching was performed by reading the refer-
ence lists of the included articles based on full text.  
Eligibility Criteria and Study Selection
Search results of the PubMed and Web of Science 
databases were screened on title and abstract accord-
ing to the inclusion and exclusion criteria presented in 
Table 2. All inclusion criteria had to be fulfilled. The 
full text of the remaining articles was retrieved if ti-
tle and abstract were considered potentially eligible. 
Each full text article was evaluated once again for eli-
gibility based on  the inclusion criteria. Literature was 
screened independently by 2 researchers (EV and EB), 
both master of science in rehabilitation sciences and 
physiotherapy, and trained in conducting systematic 
reviews by the last author (MM), who obtained a PhD 
and published several systematic reviews in the domain 
of central sensitization. 
Study Quality and Levels of Evidence in 
Individual Studies
The risk of bias, and additionally the quality of the 
used OA paradigm, were assessed for each included 
study.
Two researchers (EV and EB) independently exam-
ined the quality of the study designs using the checklists 
of risk of bias developed by EBRO-platform, provided by 
the Dutch Institute for Healthcare Improvement (CBO) 
and the Dutch Cochrane Centre (http://dcc.cochrane.
Table 1. Key words.
Population Intervention Comparison Outcome
Healthy 
 
Patients 
 
Animals
Offset analgesia
Psychophysical testing paradigms  
 
Endogenous analgesia
Conditioned pain modulation 
 
CPM 
Pain-inhibits-pain 
Diffuse noxious inhibitory control  
DNIC 
Counter-irritation 
Counter stimulation 
Heterotopic Noxious Conditioning Stimulation 
HNCS
Endogenous pain 
Inhibition 
Pain (Mesh) 
Pain evaluation 
Pain threshold (Mesh) 
Pain management (Mesh) 
 
Pain measurement (Mesh)
Analgesia (Mesh)
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org/). Depending on the study design, the checklist for 
randomized controlled trials (RCTs), case-control, or co-
hort studies was used. Each checklist assessed 6 to 9 cri-
teria or items, which are displayed in Tables 3 – 5.
The fulfillment of each item on the checklists was 
answered by either a yes (= 1 point),  no, or lack of in-
formation (= 0 points). The majority of studies did not 
use a control group, but instead all participants un-
derwent a test protocol and a control protocol. In that 
case, criteria related to the control group were inter-
preted as criteria for the control protocol. Studies were 
awarded 1 point for confounding factors, if at least 2 of 
following factors were taken into account: gender, age, 
menstrual cycle, catastrophizing, anticipation (e.g., at-
tention, expectations), genetics, or medication, based 
on a previous systematic review about the influence of 
personal factors on CPM (21).
The scores of the 2 researchers were compared, 
and in case of disagreements, a consensus meeting was 
held to achieve agreement between the researchers. In 
case the disagreement could not be resolved, a third 
decisive opinion was provided by the first author (LH), 
who is a PhD candidate in pain research and has (co-)
authored several published systematic reviews. 
The levels of evidence were assigned to the included 
articles using the EBRO-guidelines of the Dutch Institute 
for Healthcare Improvement. According to study design 
and risk of bias, the articles received a level of evidence 
A1 (= systematic review of at least 2 independent stud-
ies), A2 (= randomized, double blinded, comparative, 
Table 2. Inclusion and exclusion criteria.
Selection criteria Inclusion criteria Exclusion criteria
Population Humans, animals, healthy subjects and patients
Intervention Topic: Application of Offset Analgesia or 
mechanisms of Offset Analgesia
Topic not examining application of Offset Analgesia or 
mechanisms of Offset Analgesia
Outcome Endogenous pain inhibition Topic not examining endogenous pain inhibition
Design Clinical reports Non-clinical reports such as letters to the editor, editorial, 
reviews
Article type Full text reports Abstracts, posters
Language English, French, Dutch Other
Table 3. Scoring on the RCT checklist.
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 CROSS OVER DESIGN = RCT checklist
1. Allocation randomized? 1 1 1 1 1
2. Blinded randomization? NSI NSI NSI NSI 1
3. Patients blinded for treatment? 1 1 1 1 1
4. Blinded treatment officer? 0 0 0 0 1
5. Blinded effect assessor? NSI NSI NSI NSI 1
6. Comparable groups? 1 1 1 0 1
7. Loss to follow up 1 1 1 1 1
8. Intention to treat analysis 1 1 1 1 1
9. Comparable treatment? 1 0 1 0 1
Total score 6/9 5/9 6/9 4/9 9/9
Level of Evidence B B B B A2
Answer possibilities: Yes = 1 point; No = 0 points; No sufficient information (NSI) in article to answer (no info) = 0 points; NA = Not applicable = 
item is not included in total score
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Table 4. Scoring on the cohort checklist.
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COHORT DESIGN = cohort checklist
1. Study group well defined? 1
2. Selection bias? 1
3. Sufficient description of exposed factor? 1
4. Well defined outcome measurement? 1
5. Blinded outcome measurement? NA
6. Follow up? 1
7. Selective loss-to-follow-up 1
8. Confounders? 0
Total score 6/7
Level of evidence B
Answer possibilities: Yes = 1 point; No = 0 points; No sufficient in-
formation (NSI) in article to answer (no info) = 0 points; NA = Not 
applicable = item is not included in total score
clinical research with sufficient sample size and good 
methodological quality), B (= comparative research, 
missing at least one feature for A2, for example patient-
control and cohort studies), C (= non-comparative re-
search) or D (= experts opinion). These levels were used 
to draw and determine the strength of conclusion which 
varied between 1 and 4. With level 1 standing for the 
conclusion of at least one A1, or full consensus of at least 
2 independent A2 studies; level 2 indicates one study A2 
or full consensus of at least 2 independent studies with 
level B; level 3 for at least one article of level B or C or 
when results are conflicting; and level 4 when the con-
clusion is based on experts’ opinion.  
Additionally, a checklist for the OA paradigm was 
made to verify if the protocol was sufficiently described. 
Six items were set up as criteria to define a good de-
scription of the protocol. The fulfillment of each item 
was answered by either yes or no, corresponding to re-
spectively one or zero points.  
Data Items and Collection
Information was extracted from each included full 
text article and summarized in an evidence table. The 
following items were collected: population (healthy 
participants or patients), characteristics population 
(sample size, gender distribution, age distribution), 
Table 5. Scoring on the case-control checklist.
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CASE CONTROL / CROSS SECTIONAL DESIGN = case-control checklist
1. Sufficient description test group? 0 0 0 1 1 1 1 1 1 1 1
2. Sufficient description control group/protocol a? 1 a 0 a 1 a 1 a 1 a 1 1 a 1 a 1 1 a NA
3. Selection bias? NA NA NA NA NA 0 NA NA 1 NA 1
4. Sufficient description of OA protocol? 1 1 1 1 1 1 1 1 1 1 1
5. Blinded measurement of exposed factor? NA NA NA NA NA NA NA NA NA NA NA
6. Confounders? 0 0 0 1 1 0 0 0 1 1 1
Total score 2/4 1/4 2/4 4/4 4/4 3/5 3/4 3/4 5/5 4/4 4/4
Level of Evidence B B B B B B B B B B C
study objective, test protocol and devices, control pro-
tocol, results and conclusion, and P-value.
Answer possibilities: Yes = 1 point; No = 0 points; No sufficient information (NSI) in article to answer (no info) = 0 points; NA = Not applicable = 
item is not included in total score
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Results
Study Selection
The selection process is drafted in Fig. 2. Seventeen 
articles were included, including 5 RCTs (22-26), 10 case-
control studies (16,17,27-34), one cross-sectional study 
(35), and one prospective cohort study (36).  
Study Quality and Levels of Evidence within 
Studies
Tables 3, 4, and 5 show the results for the risk of 
bias. A consensus meeting was necessary as for 24% of 
the scored items the 2 researchers did not agree. After 
negotiation with the third researcher, full agreement 
was achieved.
Four out of 5 RCTs failed to blind the therapists, as 
they had to observe the occurrence of side effects (e.g., 
nausea, vomiting, drowsiness) (22-25). For blinding the 
effect assessor, all studies, except one (26) lost points 
given the fact that analyzation of the results was not 
blinded. Only the study of Niesters et al (26) was able to 
blind the effect assessor by blinding the research team 
until OA responses had been analyzed.
Additionally, 5 out of 12 studies (11 case-control 
Fig. 2. Flow chart study selection process. 
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and one cross-sectional) (29,30,33-35) took at least 2 
factors into consideration, all other studies lost points 
for this item as well. 
One RCT received a level A2 (26), 4 RCTs were 
downgraded to level B due to lack of blinding (22-25). 
Ten case-control studies (16,17,27-34) and one cohort 
study (36) obtained a level B. One cross-sectional study 
(35) was not being comparative and therefore received 
a level C. 
As 2 articles (25,28) scored below 50% on the 
methodological quality checklist, prudence is warrant-
ed when drawing conclusions from these articles. 
Table 6 shows the results for the quality of the OA 
paradigms. All articles defined the OA paradigm well, 
resulting in scores between 5 and 6 out of 6.  
Study Characteristics
Collected data from all studies are shown in Table 
7. Fourteen studies investigated OA in healthy partici-
pants, with sample sizes ranging from 10 (16,24) to 110 
volunteers (25). Four studies explored OA efficiency in 
patients (25,26,33,36), with sample sizes ranging be-
tween 20 (25) and 30 participants (33,36). None of the 
included studies examined OA in animals. Sixteen out of 
17 protocols used a thermal stimulus to evoke OA, only 
Hamaguchi et al (29) induced OA with a pressure stimu-
lus. Only one study (27) examined which individualized 
temperature provokes the largest OA-effect and an-
other study (31) examined the influence of assessment 
site on OA-effect. Ten studies (16,17,22,23,27,28,30,32-
34) included a constant pain trial (Fig. 1b) besides the 
OA trial. 
In 9 studies (22,23,26-28,30,34-36) an extra trial 
besides the offset and constant trial was used. Five 
studies (22,23,27,28,30) conducted a baseline trial to 
determine whether pain ratings would differ between 
1°C decrease in the OA trial and decreasing to baseline 
temperature. CPM was additionally assessed in 6 studies 
(24,26,30,34-36). Two studies (16,17) investigated the 
time-course of OA. 
Twelve studies tried to find out which mechanisms 
are underlying OA. Naugle et al (31) explored whether 
Table 6. Scoring OA paradigm.
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1: test protocol clearly described to be 
reproducible?
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
2: used device and stimulus form clearly 
described?
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
3: stimulated area clearly described? 1 1 1 1 1 1 0 1 1 0 1 0 1 1 1
4: duration of administering stimulus clearly 
described?
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
5: outcome measurement and clinimetrics 
clearly described?
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
6: eventual results and analysis clearly 
described?
1 1 1 1 1 1 1 1 NSI 1 1 1 1 1 1
Total score 6/6 6/6 6/6 6/6 6/6 6/6 5/6 6/6 5/6 5/6 6/6 5/6 6/6 6/6 6/6
Answer possibilities: Yes = 1 point; No = 0 points; No sufficient information (NSI) in article to answer (no info) = 0 points; NA = Not applicable = 
item is not included in total score.
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peripheral mechanisms trigger the OA 
paradigm by testing the occurrence of 
OA at the palm in comparison to the 
volar forearm, of which differences in 
nociceptor innervation is known. In ad-
dition, Martucci et al (22) investigated 
the influence of experimentally induced 
peripheral sensitization on OA. The in-
volvement of the central nervous sys-
tem in the mediation of OA was investi-
gated by Yelle et al (16), using a paired 
stimulus paradigm. The latter authors 
(16) determined if OA could inhibit pain 
induced by primary afferent neurons in 
another region.
Three studies (28,32,34) used func-
tional magnetic resonance imaging 
(fMRI) with a blood oxygenation level 
dependent (BOLD) signal to reveal ac-
tivated brain regions during OA, while 
Hamaguchi et al (29) used a positron 
emission tomography (PET) scan to ex-
amine the same scope.
Four other studies (23,25,26,36)  ex-
plored the central functioning of OA by 
examining the role of opioid receptors 
(using naloxone (23), tapentadol (26), 
hydromorphone treatment (36), and 
NMDA receptors (using ketamine (24)). 
Additionally, Niesters et al (24,26), 
Honigman et al (30), Nahman-Averbuch 
et al (34), Naugle and Riley (35), and Su-
zan et al (36) compared the mechanism 
of OA to CPM. 
Four articles investigated the influ-
ence of personal factors on OA magni-
tude. Three articles studied the influ-
ence of gender differences (25,30,31), 2 
studies tried to objectify if the magni-
tude of OA differs between young and 
older healthy adults (25,31), and anoth-
er study (35) examined the relation of 
physical activity with OA. 
Methods OA
All thermal protocols started with 
a baseline temperature (T0) varying 
between 32°C and 35°C. Unpleasant 
stimuli (T1) varied between 45°C and 
49°C, and painful stimuli (T2) varied 
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(DLPC) was found by 2 studies (32,34). Dissimilar find-
ings were reported concerning the mid-cingulate cor-
tex (MCC) and anterior cingulate cortex (ACC), with 
an increased MCC and equally activated ACCs activity 
shown by Yelle et al (32) and decreased MCC and ACC 
activity compared with the constant trial reported by 
Derbyshire and Osborn (28). Respectively the first au-
thors (32) also reported more deactivations of the ven-
tral medial prefrontal cortex (VMPC) during OA than 
throughout the constant pain trial. The secondary so-
matosensory cortex (S2) was less activated during OA 
compared to constant pain (28). 
Subcortical brain structures – Results regarding the 
thalamus are contrasting, with an increased activity 
reported by Yelle et al (32), and less activation of the 
thalamus during OA compared to a constant pain trial 
in Derbyshire and Osborn (28). The posterior aspect of 
the globus pallidus, which is in close proximity of the 
thalamus, also showed increased activity, although the 
rostral aspect displayed equal activation compared with 
the constant pain trial (32). 
Brain stem – Three articles (28,29,32) revealed sig-
nificantly greater activity in the periaqueductal grey 
(PAG) during OA compared to constant stimulation at 
the same point in time. However, Nahman-Averbuch et 
al (34) reported no differences in PAG activity. Never-
theless, the latter authors (34) did find a significant OA 
induced activation of the pons and medulla, which is 
supported by the results of Yelle et al (32). 
Cerebellum – An OA induced increase of cerebral 
blood flow was objectified in the cerebellum by Hama-
guchi et al (29) and supported by Yelle et al (32). How-
ever, Nahman-Averbuch et al (34) detected a significant 
decrease in cerebellar activation during OA. 
It is proven that S1 exhibits reduced activity dur-
ing OA (conclusion strength 1). Besides, it is plausible 
that the PAG, dorsolateral prefrontal cortex, insula, 
medulla, and pons are more activated during OA than 
during constant pain or rest (conclusion strength 2). 
There are indications for an OA induced increase in the 
cerebellum, although no full consensus exists (conclu-
sion strength 3).  
Spinal Mechanisms
Yelle et al (16) investigated the spatial stimulus in-
teractions of OA, when assessed simultaneously at dif-
ferent sites. They reported lower pain intensities during 
OA trials both at proximal and distal probe (both on 
forearm 50 mm apart) compared to a constant painful 
stimulation (49°C) at both probes (P = 0.0042). Simi-
between 46°C and 50°C, for details see Table 7. Four 
studies (24,25,27,31) used individualized temperatures 
to induce OA, and the highest individualized tempera-
ture (perceived pain 15/20) provoked the largest OA-
effect (27). To measure the OA effect; intensity of the 
maximum pain rating at T2 (dotted curve in Fig. 1a) and 
minimum pain rating at T3 are subtracted (∆VAS = peak 
VAS during T2 – minimum VAS during T3). Seven studies 
that included a constant pain trial (16,17,27,28,30,32,34) 
found significant decreases in pain ratings during the 
OA protocol compared to constant painful stimulation.
The duration of stimulation varied among studies 
and appliance times of the different protocols are pre-
sented in Fig. 3. Martucci et al (22) and Yelle et al (32) 
are the only 2 studies with no constant time period of 
T1 and T2, and Naugle et al (31) was the only study ap-
plying a time period of 15 seconds for T1, which made 
stabilization of the perceived pain possible.   
Underlying Mechanisms of OA
Temporal Processing
The studies of  Yelle et al (16) and Martucci et al (23) 
examined whether OA functions as a temporal filtering 
mechanism, meaning that inhibitory mechanisms could 
increase the perceived temporal contrast and reduce 
post-stimulus responses. The occurrence of OA during 
different fall rates at both 48° and 50°C was reported 
(16), indicating no decrease of pain intensity in direct 
proportion to the stimulus fall rate. In accordance, Mar-
tucci et al (23) revealed significantly decreased pain rat-
ings, for fall rates of -0.5°C/s as well as -5.0°C/s (using 
blocks of short-duration stimuli (49°C (4 – 6s)). 
It is plausible that OA functions as temporal filter-
ing mechanism, which increases the detectability of 
slow decreases in noxious stimulus intensity and induc-
es post-stimulus inhibition (conclusion strength 2).  
Brain Function 
A change in activation induced by OA has been re-
ported in multiple cortical (28,29,32,34) and subcortical 
regions (32,34), brain stem (28,29,32,34), and cerebel-
lum (29,32,34).  
Cortical brain structures – Three studies (28,32,34) 
reported less activation of contra- and ipsilateral pri-
mary somatosensory cortex (S1) during the painful 
stimulation in OA. Three studies (29,32,34) revealed 
more activation of the contralateral insula during OA 
compared to the constant pain trial. An increased OA 
induced activity of the dorsolateral prefrontal cortex 
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lar findings were found when OA was induced at the 
proximal probe and painful stimulation (49°C) at the 
distal probe, compared to constant noxious stimulation 
(49°C) at the proximal as well as the distal probe (P = 
0.0072). However, the exact opposite (noxious stimu-
lation proximal and OA distal) did not result into sig-
nificantly different pain intensities compared to painful 
stimulation (49°C) at both probes (P = 0.37). Moreover, 
potentiation of OA initiated by 2 probes was not sig-
nificant (P = 0.34). 
There are indications that OA is modulated by 
noxious stimulation within the same body region and 
that summation of OA-effect does not exist (conclusion 
strength 3). 
Fig. 3. Time of  appliance.
Central Working Opioids and 
Neurotransmitters
Three studies (23,26,36) examined if OA is (in part) 
opioid-mediated, while another study (24) examined 
NMDA-mediated involvement.
There was no significant difference between the 
OA observed in healthy volunteers after infusion of the 
NMDA receptor antagonist ketamine (∆VAS = 0.86 ± 
0.06) and placebo infusion (∆VAS = 0.91 ± 0.03) (24), 
indicating no NMDA-receptor involvement in OA. The 
study of Martucci et al (23) showed no reduction in the 
OA magnitude following remifentanil (= opioid anal-
gesic) intake (P = 0.9310), representing no disruption of 
OA during a period of opioid-induced hyperalgesia. Ad-
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and OA efficacy which was detected in women (r = 0.53, 
P = 0.04), though not in men (P = 0.56). The gender effect 
in the study of Niesters et al (25) was age-dependent, as 
no gender-differences were observed in young (6 – 19 
years) volunteers (P = 0.185), while in older adults (20 – 
80 years) significant gender differences were exposed (P 
= 0.002), with men predisposing for better OA. 
Two other studies (24,31) could not demonstrate 
significant gender differences in OA magnitude.  
Evidence for gender differences in OA magnitudes 
is conflicting (conclusion strength 3).  
Age 
Two articles (25,31) reported differences in OA mag-
nitude between younger and older adults. Niesters et al 
(25) showed a trend towards reduced OA with increas-
ing age, however only border significant differences be-
tween the age cohorts could be objectified (P = 0.054). 
This was supported by Naugle et al (31) who actually 
revealed significant differences in OA magnitude, with 
older adults exhibiting reduced OA magnitudes at the 
forearm, compared to the younger group (P = 0.048). 
However, at palm side equal responses were reported. 
There are indications for decreasing OA magni-
tudes with aging (conclusion strength 3). 
Physical Activity
Only one study evaluated the influence of physi-
cal activity on OA magnitude (35). Although a positive 
effect of more vigorous and total physical activity on 
CPM-effect was found, no outcome on the Interna-
tional Physical Activity Questionnaire predicted OA 
magnitude.
There are indications for no predictive value of 
physical activity level to OA efficacy, however evidence 
is limited (conclusion strength 3). 
OA in Patients
In neuropathic patients OA effects seemed to be 
delayed and smaller compared to healthy controls 
(P < 0.001), even though the individual test tempera-
tures and mean peak VAS did not significantly differ 
between patients and healthy controls (respectively P 
=  0.91 and  P = 0.44) (25). Following ketamine and mor-
phine treatment, pain scores were significantly lower in 
neuropathic pain patients but no effect on OA was de-
tected (25). Also in patients with diabetic polyneuropa-
thy (26), chronic neuropathic (radicular) pain (36), and 
patients who suffered from cerebellar infarction 1 to 11 
years ago (33), no clear OA-effect could be objectified. 
ditionally, the OA response was not influenced by oral 
hydromorphone (= opioid analgesic) treatment in the 
study of Suzan et al (36) (P =  0.44). Naloxone (= opioid 
antagonist) (P = 0.3211) did likewise not influence the 
OA magnitude, which indicates no opioid contribution 
as well (23). This is supported by the results of Niesters 
et al (26), which showed that tapentadol (= opioid ago-
nist and norepinephrine reuptake inhibitor) treatment 
had no effect (P = 0.78) on OA magnitude. 
It is proven that OA is not opioid dependent (con-
clusion strength 1). Besides, there are indications that 
OA is not NMDA-receptor dependent either (conclusion 
strength 3). 
Peripheral Mechanisms
Two studies (22,31) investigated predominantly pe-
ripheral mechanisms during OA. 
Martucci et al (22) suggested that OA would be 
disrupted during a state of experimentally induced sen-
sitization. Sensitization at the forearm was induced by 
applying capsaicin cream followed by a heat stimulus. 
Results showed no significant alteration in OA magni-
tude (P = 0.56). To determine the influence of afferent 
fibers on OA effect, Naugle et al (31) analyzed distinct 
afferent fibers by positioning a probe on the palm and 
a separate probe on the volar forearm. Results indicat-
ed only OA effects at the forearm.   
There are indications that OA is not disrupted 
by experimentally induced sensitization (conclusion 
strength 3), however, peripheral mechanisms might be 
involved in initiating OA (conclusion strength 3). 
Duration
Two studies (16,17) investigated the time-course of 
OA and revealed that minimum pain intensity ratings 
during OA were significantly lower than minimum pain 
ratings evoked by constant thermal stimulation at T1 
(P < 0.01) in the 20 seconds following the 1°C decrease. 
This analgesia lasted approximately 15 seconds. 
It is plausible that the analgesia evoked by OA lasts 
15 seconds (conclusion strength 2). 
Individual Factors Influencing OA
Gender
Four studies investigated the effect of gender on 
OA efficacy (24,25,30,31). Two articles (25,30) reported 
significantly higher OA magnitudes in men compared to 
women. The study of Honigman et al (30) additionally 
exposed a negative correlation between pain sensitivity 
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Decreased OA-effects in neuropathic patients are 
proven (conclusion strength 1). The observations from 
patients with cerebellar infarction, together with brain 
imaging studies, give indications for involvement of the 
cerebellum in OA (conclusion strength 3).   
Differences between OA and CPM  
Four articles (24,30,34,35) revealed different mech-
anistic properties of endogenous analgesia through 
CPM versus OA in healthy people. 
The study of Nahman-Averbuch et al (34) exhibited 
a greater reduction of activity in brain regions associ-
ated with afferent nociceptive processing during CPM 
than during OA, although S1 displayed greater deacti-
vation in OA. Subsequently, modulation of nociceptive 
processing was more activated during OA. In multiple 
levels of the brain stem, CPM induced reduced activ-
ity, while OA produced increases in activity. For more 
detailed information see Nahman-Averbuch et al (34).   
Moreover, Niesters et al (24) revealed no change 
in OA magnitude after ketamine administration, but a 
reduced CPM response was observed, as pain responses 
were significantly higher (P < 0.01). Additionally, one 
study in diabetic polyneuropathy patients (26) revealed 
a higher CPM efficacy following tapentadol treatment 
(P < 0.001) while OA magnitude was not altered (P = 
0.78). However, hydromorphone did not significantly 
influence CPM (P = 0.22) or OA (P = 0.44) in neuropathic 
patients (36).
Interestingly, Honigman et al (30) revealed an addi-
tive effect of CPM on OA in men, as an OA+CPM condi-
tion showed significantly greater pain reduction than 
an OA standalone condition (P = 0.003) and a trend to-
wards additive effects of OA on the standalone condi-
tion of CPM in men (P = 0.07). 
Finally, one study (35) examined possible differ-
ences in individual factors influencing the magnitude 
of OA and CPM. Self-reported total and vigorous activ-
ity in healthy people did predict CPM-effect, while no 
correlation with OA-effect could be detected.
CPM and OA plausibly rely on different mecha-
nisms (conclusion strength 2) and are possibly influ-
enced by different personal factors such as daily activity 
levels (conclusion strength 3). Nonetheless, indications 
suggest that both may influence one another (conclu-
sion strength 3).  
discussion
This systematic review was developed to provide 
an overview of the current knowledge regarding OA, 
more specifically to objectify the methods used in OA 
assessment, unravel the mechanisms triggered by OA, 
map the personal factors that influence OA (assess-
ment), represent OA in patients, and to compare OA 
with CPM. 
Methods OA
The present review objectifies OA as a pain proto-
col that is increasingly used in assessment to measure 
endogenous pain inhibition. The included OA protocols 
are reasonably similar, which makes comparison of the 
study protocols possible. Sixteen out of 17 studies used 
quantitative sensory testing (QST) with hot tempera-
ture to provoke OA-effects. However, only 4 studies 
(24,25,27,31) used individualized temperatures to pro-
voke OA. An individually determined temperature (per-
ceived pain 15/20) seems to induce greater OA-effects 
compared to lower temperatures, however evidence is 
preliminary. Additionally, OA-effects are possibly de-
pendent on the assessment site (31), though further re-
search is necessary.  Since no gold standard exists, small 
differences in protocols are present. For instance, 7 
studies (24-26,29,31,35,36) lacked additionally assessed 
constant trials. These trials are recommended to calcu-
late effect sizes of the OA magnitude since part of the 
OA-effect can be ascribed to adaptation (27). For this 
reason, future OA assessment should include constant 
trials in their protocol as it was originally described by 
Grill and Coghill (17). 
Underlying Mechanisms of OA
OA probably functions as a temporal filtering 
mechanism, which enhances the detectability of nox-
ious stimulation and induces post-stimulus inhibition 
(16,23). This post-stimulus inhibition appears to last for 
15 seconds (16,17) which is important for the develop-
ment of OA assessment protocols. New protocols should 
also take the spatial interactions that possibly influence 
OA into account: for example; the asymmetric spatial 
interactions found in the study of Yelle et al (16) that 
substantiates the modulation of OA by other noxious 
stimulation at the same body region. Since summation 
of OA was not objectified in this latter study, central 
mechanisms at the spinal level as well as descending in-
hibitory tracts seem to be involved in OA (16).
The large involvement of central mechanisms 
in OA is clearly established by brain imaging studies. 
These studies demonstrate reduced activity of the S1 
during OA (28,32,34) that goes along with increased ac-
tivation during OA compared to constant pain stimuli 
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in brain regions associated with descending pain inhibi-
tory pathways; PAG (28,29,32), dorsolateral prefrontal 
cortex (32,34), insula (29,32,34), medulla (32,34), pons 
(32,34), and cerebellum (29,32,33). 
Because of the partial overlap with brain activity 
in the regions associated with placebo (expectation) 
(37), distraction (38), and mindfulness (39), cognitive 
processes may be involved in OA as well (34). Moreover, 
Loggia et al (40) revealed that lower pain-anticipatory 
lateral prefrontal activity contributes to hyperalgesia 
induced by negative cognitions (catastrophizing) in fi-
bromyalgia patients. Additionally, impaired OA-effects 
as well as reduced placebo analgesia are exhibited in 
patients with cerebellar infarction (33). Although the 
exact contribution of cognition in OA-magnitude needs 
further study, cognitive involvement in OA-effect is 
conceivable.  
Individual Factors Influencing OA
Studies examining the influence of personal factors 
on OA are scarce. Gender studies point to greater OA 
magnitudes in men, which is in accordance with CPM-ef-
fects (21), however, no full consensus exists (24,25,30,31). 
In addition, there are indications for decreased OA-ef-
fects with aging (25,31), but evidence is limited. The age-
related effect of the decrease in β-endorphins at rest and 
a smaller release of β-endorphins during painful stimu-
lation are possible explanations for this decrease (41). 
Thus far, only one study (35) investigated the influence 
of physical activity and did not find a relation. Neverthe-
less, evidence indicates that physical activity considerably 
improves cognitions and efficient brain functions (42), 
and as described above, these may be involved in gener-
ating the OA phenomenon. Subsequently, improved OA 
magnitudes with higher physical activity levels could be 
expected and needs further exploration. As OA seems to 
be more brain derived and the influence of anticipation 
on CPM is frequently reported (43-45), further research 
about these factors in OA is necessary. The same applies 
for other modifiable factors linked to pain and assess-
ment (attention, expectations, catastrophizing, anxiety, 
etc.).
Non-modifiable personal factors like genetics 
(46,47) and hormonal factors (48,49) have been report-
ed to influence CPM, and are possibly also influencing 
OA, but studies are lacking.  
OA in Patients
Current literature does provide indications 
for decreased OA-effects in neuropathic patients 
(25,26,33,36). As effective descending inhibitory path-
ways protect progression of chronic neuropathy and 
improves quality of life (50), research regarding neu-
ropeptides etc. involved in these pathways is necessary. 
As mentioned earlier, impaired endogenous pain 
inhibition in patients with central sensitization, as-
sessed by CPM, is frequently reported (2,5,9,12). As OA 
probably evaluates more brain derived pain modula-
tion compared to CPM, impaired OA is also assumed in 
these patients. This is supported by a very recent study 
of Oudejans et al (51) that displayed reduced OA-ef-
fects in patients with fibromyalgia. These authors ad-
ditionally demonstrated lower pain perception and 
pain tolerance thresholds in patients with reduced OA. 
Therefore, it can be hypothesized that hyperexcitability 
to heat pain plays a role in the loss of OA-effect, how-
ever, more research is necessary. Additionally, whether 
the loss in OA-effect in these patients with central sen-
sitization is more peripheral, central, or a combination, 
should be further investigated.   
Differences Between OA and CPM  
The OA mechanism differs in all probability from 
the CPM phenomenon (24,30,34,35). Next to the above 
mentioned differences between OA and CPM, aberrant 
brain activation is an important feature; for example, 
activity reductions in brain regions related to afferent 
nociceptive processing observed during CPM and in-
creased activations in circuitry subserving pain modula-
tion through OA. These findings probably reflect more 
brain derived pain modulation during OA as compared 
to CPM (34). In line with this, it is important to note 
that CPM is the psychophysical spatial assessment tool 
to measure multiple inhibitory mechanisms, such as 
DNIC (spinal-medullary-spinal loop), heterotopic inhibi-
tion mediated by local circuits at the spinal level, and 
heterotopic noxious conditioning stimulation (supraspi-
nal top down pathways) (52,53). As for OA, current evi-
dence supports the activation of supraspinal inhibitory 
top-down pathways and only indications for mediation 
at the spinal level exists.
Concomitant are the diverse effects of medication 
on the different pain assessments. Opioids and NMDA-
receptors do not seem involved in OA (23,26,36), how-
ever, results regarding the involvement of opioids in 
CPM are contradictory (26,36). Subsequently, tempo-
ral summation appears to be more opioid dependent 
compared to CPM (54). Therefore, the opioid induced 
analgesic effects may be more applicable at spinal than 
supraspinal levels (54). Hence, to evaluate the opioid-
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mediated descending pathways, OA and CPM assess-
ment should feasibly be accompanied by other tools.
Preliminary evidence objectified the modulation 
of OA by other noxious stimulation (16). This is some-
what contrasting to the indications that OA is not dis-
rupted by capsaicin-induced tissue sensitization at the 
assessment site (22), although probably different path-
ways are involved. Regarding capsaicin-induced sensi-
tization, one should note that despite predominantly 
evaluating peripheral mechanisms, the involvement 
of central components is conceivable (55). To the best 
of our knowledge, only the study of Oono et al (56) 
investigated the effect of induced acute pain on CPM. 
These authors reported no influence of experimentally 
induced noxious stimulation of the temporal mandibu-
lar joint on CPM-effect. Albeit, evidence is preliminary 
and no consensus exists, these studies give implications 
for aberrant OA and normal CPM effects in patients 
with already clinical (sub)acute pain and no influence 
of assessment site tissue sensitization in OA. Currently, 
studies only investigated CPM-effects in patients with 
acute postoperative pain. The multiple aspects associ-
ated with postoperative pain (e.g., medication, immo-
bilization, psychological factors, etc.) may shadow pure 
CPM-effects (15). Consequently, further research into 
OA and CPM in patients with acute pain and patients 
with central sensitization are recommended.  
Hence, CPM and OA appear to rely on different 
mechanisms. Nevertheless, further research is warrant-
ed to disentangle OA and CPM mechanisms and to dis-
cover their specific pathways. 
Limitations and Suggestions
Five articles (16,17,24,28,34) used a sample size of 
less than 15 participants, probably presuming a power 
that is insufficient to make firm conclusions. Besides, 2 
articles scored below 50% on the risk of bias checklist 
(25,28). All RCTs scored one point for blinding the pa-
tient, because self-reported pain is proven to be a valid 
and reliable assessment method (57) and is the only 
suitable option in the OA protocol. Nonetheless, after 
receiving the infusion (naloxone, tapentadol, remifent-
anil, ketamine), different side effects occurred (nausea, 
dizziness, vomiting) (23,24,26). Therefore, it is possible 
that experiencing side effects following the experi-
mental infusion and not following the control infusion 
could have compromised blinding of the participants 
regarding the experimental/control intervention and 
thus influenced their self-reported pain intensity due 
to certain expectations. It is recommended for future 
studies to give a clear description regarding the blind-
ing of therapists, assessors, and participants. 
Finally, search strategy was taken wide and no pre-
defined directions were made, because research into 
OA is currently limited. Therefore a large variety of 
research perspectives (e.g., inventorying different as-
sessment protocols, influencing factors, central and pe-
ripheral mechanisms, etc.) of OA were included in this 
review. The methodological differences accompanied 
by the different perspectives of these studies might 
have influenced the outcomes and therefore could have 
influenced conclusions made by the present review.   
Clinical Implications
Clinical applications of OA are currently not clear 
due to limited available research. Nevertheless, future 
OA studies may improve the understanding of (the 
pathophysiology of) various chronic pain conditions. 
Consequently, new treatments can be developed based 
on a new understanding generated from these research 
projects. Based on the preliminary evidence regarding 
the overlap of brain activity in regions associated with 
cognitive processes, future research should focus more 
on these mechanisms. For instance, there might be a 
possibility to potentiate OA by attention and expecta-
tions (27). Besides the fact that OA can serve as an as-
sessment tool for the efficacy of endogenous pain in-
hibition, further research is necessary to examine how 
OA can be of clinical relevance, e.g., in the assessment 
of the relation between cognitions and pain and the 
effect of more cognition-targeted therapies.  
conclusion
The findings of this review objectify OA as a tem-
poral sharpening mechanism, which can function as a 
non-opioid mediated assessment tool for endogenous 
pain inhibition. OA activates brain regions such as PAG, 
dorsolateral prefrontal cortex, insula, medulla, pons, 
and cerebellum, indicating strong brain derived pain 
modulation. Hence, further research of OA as an assess-
ment tool in e.g., the evaluation of cognition-targeted 
therapies is warranted. Besides, evidence regarding OA 
in (sub)acute pain and central sensitization patients, 
and the influence of personal factors on OA is currently 
scarce. That reinforces the need for further research 
exploring OA, also prospectively, to support treatment.
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